Position in LUNG
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$177,004
-$355 QoQ
Shares Held
136,157
-1.0% QoQ
Ownership
0.317%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 108 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,693,166 across 42 Medical Devices names. LUNG ranks #37 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in LUNG
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,004 | 136,157 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $177,359 | 137,488 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $892,314 | 403,762 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,223,856 | 755,467 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,097,447 | 423,725 | Shares | Sole | 2025-07-22 | |
| 2024-12-31 | $582,643 | 85,809 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $536,951 | 64,771 | Shares | Sole | 2024-11-05 | |
| 2023-12-31 | $252,348 | 19,792 | Shares | Sole | 2024-02-16 | |
| 2022-12-31 | $1,327,674 | 157,494 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||